Clinical Trials Browser

Phase 2/3 × NIH × Celecoxib × Clear all

NCT00006124 2013-02-13

Celecoxib in Treating Patients With Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms